379 related articles for article (PubMed ID: 16542506)
1. Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
Bramlage CP; Häupl T; Kaps C; Ungethüm U; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR
Arthritis Res Ther; 2006; 8(3):R58. PubMed ID: 16542506
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis.
Lories RJ; Derese I; Ceuppens JL; Luyten FP
Arthritis Rheum; 2003 Oct; 48(10):2807-18. PubMed ID: 14558086
[TBL] [Abstract][Full Text] [Related]
3. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis.
Schedel J; Gay RE; Kuenzler P; Seemayer C; Simmen B; Michel BA; Gay S
Arthritis Rheum; 2002 Jun; 46(6):1512-8. PubMed ID: 12115181
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
[TBL] [Abstract][Full Text] [Related]
5. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium.
Firestein GS; Berger AE; Tracey DE; Chosay JG; Chapman DL; Paine MM; Yu C; Zvaifler NJ
J Immunol; 1992 Aug; 149(3):1054-62. PubMed ID: 1386092
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
[TBL] [Abstract][Full Text] [Related]
7. Expression of the precursor of secretoneurin, secretogranin II, in the synovium of patients with rheumatoid arthritis and osteoarthritis.
Sprott H; Pap T; Rethage J; Wintersberger W; Gay RE; Bradley LA; Uebelhart D; Gay S
J Rheumatol; 2000 Oct; 27(10):2347-50. PubMed ID: 11036828
[TBL] [Abstract][Full Text] [Related]
8. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression.
Neidhart M; Rethage J; Kuchen S; Künzler P; Crowl RM; Billingham ME; Gay RE; Gay S
Arthritis Rheum; 2000 Dec; 43(12):2634-47. PubMed ID: 11145021
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues.
van der Pouw Kraan TC; van Gaalen FA; Kasperkovitz PV; Verbeet NL; Smeets TJ; Kraan MC; Fero M; Tak PP; Huizinga TW; Pieterman E; Breedveld FC; Alizadeh AA; Verweij CL
Arthritis Rheum; 2003 Aug; 48(8):2132-45. PubMed ID: 12905466
[TBL] [Abstract][Full Text] [Related]
10. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics.
Steenvoorden MM; Tolboom TC; van der Pluijm G; Löwik C; Visser CP; DeGroot J; Gittenberger-DeGroot AC; DeRuiter MC; Wisse BJ; Huizinga TW; Toes RE
Arthritis Res Ther; 2006; 8(6):R165. PubMed ID: 17076892
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis.
Schedel J; Distler O; Woenckhaus M; Gay RE; Simmen B; Michel BA; Müller-Ladner U; Gay S
Ann Rheum Dis; 2004 Oct; 63(10):1205-11. PubMed ID: 15361372
[TBL] [Abstract][Full Text] [Related]
12. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry.
Tilleman K; Van Beneden K; Dhondt A; Hoffman I; De Keyser F; Veys E; Elewaut D; Deforce D
Proteomics; 2005 May; 5(8):2247-57. PubMed ID: 15846842
[TBL] [Abstract][Full Text] [Related]
13. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity.
Galligan CL; Baig E; Bykerk V; Keystone EC; Fish EN
Genes Immun; 2007 Sep; 8(6):480-91. PubMed ID: 17568789
[TBL] [Abstract][Full Text] [Related]
14. Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease.
Daans M; Lories RJ; Luyten FP
Arthritis Res Ther; 2008; 10(5):R115. PubMed ID: 18816401
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness.
Grcevic D; Jajic Z; Kovacic N; Lukic IK; Velagic V; Grubisic F; Ivcevic S; Marusic A
J Rheumatol; 2010 Feb; 37(2):246-56. PubMed ID: 20008919
[TBL] [Abstract][Full Text] [Related]
16. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis.
Scharstuhl A; Vitters EL; van der Kraan PM; van den Berg WB
Arthritis Rheum; 2003 Dec; 48(12):3442-51. PubMed ID: 14673995
[TBL] [Abstract][Full Text] [Related]
17. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
[TBL] [Abstract][Full Text] [Related]
18. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR
Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.
Ospelt C; Brentano F; Rengel Y; Stanczyk J; Kolling C; Tak PP; Gay RE; Gay S; Kyburz D
Arthritis Rheum; 2008 Dec; 58(12):3684-92. PubMed ID: 19035519
[TBL] [Abstract][Full Text] [Related]
20. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis.
Verschueren PC; Lories RJ; Daans M; Théate I; Durez P; Westhovens R; Luyten FP
Ann Rheum Dis; 2009 Jan; 68(1):117-23. PubMed ID: 18276742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
